Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer

NCT00364754 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic/Recurrent Breast Cancer

Interventions

DRUG: Tesmilifene (YMB 1002)

Sponsor

YM BioSciences